logo
The Importance and Applications of Artificial Intelligence in Healthcare

The Importance and Applications of Artificial Intelligence in Healthcare

Ammon19-07-2025
There is a significant transformation occurring in healthcare, driven by artificial intelligence (AI), which is expected to enhance healthcare management efficiency, make care more patient-centered, and improve clinical services. In Jordan, we are not far removed from these developments. However, I am critical of the current direction, which tends to marginalize clinical physicians—the true bridge between healthcare and patients. When a patient visits a hospital, they are not primarily concerned with healthcare administration or supporting medical and non-medical staff, important as they may be. Rather, the patient seeks to see and consult with a clinical specialist.
AI utilizes complex algorithms to analyze vast amounts of input data to find patterns that support healthcare services, such as automation, reducing human error, predicting outcomes, and contributing to the development of remote virtual clinics. In my opinion, the influence of AI is still largely confined to administrative procedures, policies, and health system management, rather than being fully integrated into practical clinical care. This raises the question of what aspects of AI we should adopt in clinical practice and what we should leave aside.
I do not foresee AI replacing doctors in the near future. Instead, it will enhance certain diagnostic processes, such as radiological and laboratory test interpretation. However, clinical assessment— the cornerstone of medical practice—will remain reliant on human physicians and their acquired knowledge and clinical skills. Let me illustrate this point: when MRI technology first emerged, many expected it to significantly reduce the need for diagnostic physicians. However, we later learned that human interpretation is crucial. For instance, if we perform spinal MRIs on people without any back pain, we find that 60% show disc changes. In many of these cases, the changes are significant and similar to those in patients with severe pain. Thus, a clinical assessment is essential to correlate imaging findings with the patient's symptoms. Moreover, not all large disc herniations are clinically significant. As a clinical physician, I may choose to treat a smaller disc herniation if it is the true cause of symptoms, and leave the larger, asymptomatic ones untreated—for the sake of better patient outcomes.
This example, which can be extended to AI, demonstrates that while data analysis and prediction can assist the physician, clinical evaluation and decision-making remain human responsibilities.
As for AI chatbots in virtual health, the social factor must not be overlooked. Our clinical experience tells us that patients are not satisfied speaking only to nurses or physician assistants—they feel reassured only after meeting the specialist. Will patients in our region accept or trust medical advice from a chatbot? In my experience, patients are influenced by digital information (like that from AI systems), but do not trust it fully nor consider it a substitute for direct consultation with a qualified physician. Future generations may differ, but that remains to be seen.
AI may prove useful in remote monitoring—such as in epilepsy diagnostics, cardiac monitoring, or sleep studies. These applications are crucial if implemented properly, as they can reduce hospital admissions, conserve resources, and provide better data on the patient's condition by observing them in their natural home environment.
Finally, the psychological factor—not mental illness per se, but emotional well-being—must be considered. Can AI assist in this area? If so, it would be a significant advancement, as stress, anxiety, and psychological pressure play major roles in the onset and progression of many symptoms, and they can influence treatment outcomes. One relevant example is pain—an important aspect of our clinical work. Pain is a subjective experience, difficult to measure, and varies widely among individuals. Some people are more sensitive and have a lower pain tolerance, which may lead to dissatisfaction with treatment and healthcare services.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Aaron Judge officially on IL as Yankees activate Amed Rosario after trade
Aaron Judge officially on IL as Yankees activate Amed Rosario after trade

New York Post

time4 hours ago

  • New York Post

Aaron Judge officially on IL as Yankees activate Amed Rosario after trade

Aaron Judge is officially on the shelf. The Yankees placed the two-time AL MVP on the 10-day injured list Sunday, a day after he was diagnosed with a right flexor strain. Advertisement Judge's spot on the active roster was filled before Sunday's finale against the Phillies by utilityman Amed Rosario, whom the Yankees acquired in a trade with the Nationals on Saturday night. The ex-Met plays both the infield and outfield, giving the Yankees some insurance beyond their new starting outfield of Cody Bellinger, Trent Grisham and Jasson Domínguez. There had been cries from the fan base for top prospect Spencer Jones to be called up to replace Judge, but the red-hot center fielder missed Friday and Saturday's games at Triple-A Scranton/Wilkes-Barre with back spasms. The Yankees officially placed Aaron Judge on the injured list on Sunday. JASON SZENES/ NY POST Advertisement He is also not yet on the 40-man roster, and with the Yankees expected to make more trades in the coming days ahead of Thursday's deadline, they need to keep some flexibility with opening spots on the 40-man. CHECK OUT THE LATEST MLB STANDINGS AND YANKEES STATS Everson Pereira and Bryan De La Cruz are the two Triple-A outfielders that are on the 40-man roster. The Yankees could have opted to bring one of them up in addition to activating Rosario, but doing so would have meant designating Oswald Peraza for assignment. That may still happen in the coming days or weeks, but for now, the Yankees are keeping their depth. Advertisement The Yankees activated Amed Rosario Sunday after they acquired him in a trade with the Nationals. Rafael Suanes-Imagn Images As for Judge, the Yankees are hoping that they have dodged a bullet by Saturday's MRI revealing the elbow flexor strain and not any UCL damage. They believe he could come off the IL after a minimum stay and then strictly DH upon his return before beginning to ramp up his throwing. The Yankees on Sunday also called up lefty Brent Headrick as a fresh arm for a battered bullpen after optioning Allan Winans on Saturday night.

Breast cancer warning issued to all women as common sign won't always appear
Breast cancer warning issued to all women as common sign won't always appear

Daily Mirror

time12 hours ago

  • Daily Mirror

Breast cancer warning issued to all women as common sign won't always appear

More difficult to notice and poorly understood, lobular breast cancer is finally coming under the spotlight but it's not as easy to spot the signs, especially one common one woman look for Lobular breast cancer, also known as invasive lobular carcinoma (ILC), is more common than ovarian and skin cancer yet there is little awareness of it. According to Cancer Research UK, one in seven women will be diagnosed with breast cancer in their lifetime and around 15% of those will have ILC. ‌ BBC presenter Victoria Derbyshire, 56, was diagnosed with the disease in 2015. ILC is different to the most common form of ductal breast cancer. Instead of starting in the breast ducts, it starts in the lobules, the glands that produce milk, and grows in a spider's web pattern. Cancer cells infect the tissue around the glands and rarely show in lumps, so it is harder to spot and likely to be diagnosed later. ‌ At least a fifth of ILC cases return years later. When this happens, the cancer becomes even harder to treat. And yet it's an under-diagnosed subtype of breast cancer that is underfunded and poorly understood. ‌ Kate Ford, a campaigner from the Lobular MoonShot Project (LMSP), says, 'The basic biology of this disease has never been studied and it has no specific treatment. ILC needs a moon shot approach – a fast injection of cash – to research funding.' On 24 June, 22 women led by LMSP Founder Dr Susan Michaelis, who sadly passed away from ILC on 9 July, held a vigil outside 10 Downing Street and delivered a petition backed by more than 350 MPs to the Prime Minister, calling for urgent funding for ILC research. ‌ Symptoms to watch out for Lobular breast cancer rarely forms lumps. Instead, the things to look out for include an area of thickening or swelling around the breast, a change in the nipple, for example it becoming inverted, or a change in the skin, such as dimpling, puckering or even a small new mark. Don't ignore other changes ‌ Cancer Research UK suggests people should also look out for pain and itching, a new lump in your breast or armpit, a change in the size, shape or feel of your breast, skin changes in the breast such as a rash or redness of the skin, fluid leaking from the nipple in a woman who isn't pregnant or breastfeeding and/or changes in the position of the nipple. If you see any of these symptoms you're advised to visit your doctor. Get a diagnosis Your GP will refer you to a clinic if they believe you might have ILC. They will examine your breasts and check for swollen lymph nodes. They may use a mammogram, an ultrasound if you're under 35, a biopsy or an MRI scan. MRI and biopsy are the most effective detection tools for ILC. Mammograms and ultrasound often fail to show the presence of the disease. ‌ How ILC is treated ILC is currently treated with chemotherapy, surgery and drugs to reduce the level of oestrogen, which cancer cells need to grow. Chemo works best on fast-dividing cells, but lobular breast cancer is not fast dividing, so the efficacy of chemo on ILC is not entirely understood. Depending on the size and abnormality, whether cells have receptors for drugs, your general health and age, a doctor will consider the best treatment, but generally it is the same as for the more common types of breast cancer. Hope for the future ‌ The Lobular Moon Shot Project is campaigning to raise £20min government funding to carry out vital research on ILC in partnership with the Manchester Breast Centre and led by breast biology expert Professor Rob Clarke.'With this funding, we could potentially develop a drug and begin testing it on patients within the next five years,' he says. "The fear of recurrence is always with me" Lobular Moon Shot Project campaigner, teacher and mum-of-three Katie Swinburne, 49, was diagnosed with ILC in 2023. ‌ 'Prior to my diagnosis, I was extremely fit and healthy, and took care with the food I ate. I remember the morning I found a lump very clearly. It appeared overnight after two years of other symptoms including pain and itching. It was extremely large, but in my ignorance I thought it was a cyst. 'I went to see my GP and was sent to have a mammogram, the nan ultrasound. The sonographer felt the lump but was confident there was nothing to worry about. He performed a biopsy to try and establish what the lump was. ‌ 'At my next appointment, a consultant came in, followed by a nurse. I was soon to learn the nurse was a Macmillan nurse. I was smiling and chatting away to the consultant, expecting to be sent on my way, when he said, 'We have the results – you have an invasive lobular carcinoma.' 'Hearing the words 'you have cancer' is like nothing else. My life, my body and my future were no longer assured. At the time of my diagnosis, my children were 10, 12 and 14. The thought of leaving them left me breathless. 'A whirlwind of appointments followed, including CT, MRI and DEXA scans. I had a double mastectomy and dose-dense chemotherapy, then radiotherapy. The nurses are angels. They hold your hand through it all. You find reserves you never knew you had. 'The fear of recurrence is always with me. I'm two years on from diagnosis and still too young for screening. Had that lump not appeared, my story might be very different. I think we need to start education and screening at a much younger age.' The Macmillan Support Line offers free, confidential support to people living with cancer and their loved ones. Call for free within the UK on 0808 808 0000

Aaron Judge flexor strain: When will injured Yankees star return? Here's what's said about recovery time
Aaron Judge flexor strain: When will injured Yankees star return? Here's what's said about recovery time

Hindustan Times

time16 hours ago

  • Hindustan Times

Aaron Judge flexor strain: When will injured Yankees star return? Here's what's said about recovery time

Aaron Judge, the New York Yankees MVP, will be spending some time off the field, after being diagnosed with a flexor strain. Aaron Judge is in an Al MVP race with Cal Raleigh, the Seattle Mariners star catcher.(Reuters) Manager Aaron Boone shared the news of his injury. Judge, their superstar slugger and lead for the Al MVP race, will be put on IL due to a flexor strain in the right elbow, Boone shared with reporters. There is no UCL tear. Also Read | Phillies offense continues to roll in win over Yankees Aaron Judge missed Saturday's 9-4 loss to the Philadelphia Phillies due to an 'elbow issue,' manager Aaron Boone had said beforehand. He added that Judge was unable to 'really throw from the outfield' and had undergone an MRI, Yahoo Sports reported. How long will Aaron Judge be out? Judge is expected to be away from the team for ten days. When he's back in the action again, Judge will be eased in, Boone has hinted. However, he will be coming back to the lineup as the designated hitter. He will begin to throw before eventually returning to outfield, the manager detailed. When did Aaron Judge get injured? It remains unclear when exactly Judge suffered the injury. He was seen wincing and gripping his right hand after a throw, during Tuesday night's win against Toronto Blue Jays. The next day, Judge did not play the right field, but was the designated hitter, with Boone stating that the player was 'OK'. Aaron Judge's race for Al MVP Judge is in an Al MVP race with Cal Raleigh, the Seattle Mariners star catcher. Over 103 games, Judge leads in four stats – batting average (.342), OPB (.449), slugging (.711) and OPS (1.160). Raleigh, meanwhile, leads the majors in homers (39) and entered Saturday trailing Judge's 84 RBI by one. As for the Yankees, they finish a three-game series with the Phillies on Sunday afternoon and also finish their homestand with four games against the Tampa Bay Rays. Then, they will face the Miami Marlins and Texas Rangers.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store